oxybutynin and mobic
oxybutynin has been researched along with mobic in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ding, X; Li, X; Pan, Y; Pu, T; Sun, Y; Wang, Q; Yang, Y | 1 |
| He, Z; Jiang, Q; Liu, C; Ma, P; Sun, M; Sun, Y; Wang, J | 1 |
| Almodovar, J; Aparicio-Solis, FO; Castilla-Casadiego, DA; Choudhury, D; Coetzee, JF; Crowell, AD; Gonzalez-Nino, D; Greenlee, LF; Miranda-Muñoz, KA; Powell, J; Prinz, G; Roberts, JL; Rosales, AM; Servoss, SL; Zhang, Y; Zou, M | 1 |
Reviews
1 review(s) available for oxybutynin and mobic
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
5 other study(ies) available for oxybutynin and mobic
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pharmacokinetics and pharmacodynamics of glycyrrhetinic acid with Paeoniflorin after transdermal administration in dysmenorrhea model mice.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Synergism; Drugs, Chinese Herbal; Dysmenorrhea; Female; Glucosides; Glycyrrhetinic Acid; Meloxicam; Mice; Monoterpenes; Skin Absorption; Thiazines; Thiazoles; Tissue Distribution; Transdermal Patch | 2016 |
Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
Topics: Adhesives; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diethylamines; Drug Liberation; Male; Meloxicam; Muscles; Oleic Acid; Permeability; Rabbits; Rats, Sprague-Dawley; Skin; Skin Absorption; Skin Irritancy Tests; Thiazines; Thiazoles; Tissue Distribution; Transdermal Patch | 2018 |
Biodegradable microneedle patch for delivery of meloxicam for managing pain in cattle.
Topics: Administration, Cutaneous; Animals; Cattle; Chitosan; Drug Delivery Systems; Meloxicam; Needles; Pain; Pain Management; Skin; Transdermal Patch | 2022 |